prof. dr. B. (Bob) Wilffert

Head of Department PharmacoTherapy, -Epidemiology and -Economics

Research

Postal address:
A Deusinglaan
1
Gebouw 3214, ruimte 0466
Groningen
Netherlands
Phone: +31 50 363 7576
  1. 2019
  2. Osmanova, D. Z., Freidin, M. B., Fedorenko, O. Y., Pozhidaev, I. V., Boiko, A. S., Vyalova, N. M., ... Ivanova, S. A. (2019). A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. BMC MEDICAL GENETICS, 20(Suppl 1), 47. https://doi.org/10.1186/s12881-019-0773-3
  3. Boiko, A. S., Ivanova, S. A., Pozhidaev, I. V., Freidin, M. B., Osmanova, D. Z., Fedorenko, O. Y., ... Loonen, A. J. M. (2019). Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors. The World Journal of Biological Psychiatry, 1-6. https://doi.org/10.1080/15622975.2018.1548780
  4. Levchenko, A., Vyalova, N., Pozhidaev, I. V., Boiko, A. S., Osmanova, D. Z., Fedorenko, O. Y., ... Ivanova, S. A. (2019). No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia. Human Psychopharmacology, 34(1), [e2685]. https://doi.org/10.1002/hup.2685
  5. Pozhidaev, I., Osmanova, D., Fedorenko, O., Vyalova, N., Semke, A., Wilffert, B., ... Ivanova (Svetlana Ivanova), S. A. (2019). The study of dopamine receptor genes in patients with schizophrenia. European Neuropsychopharmacology, 29(Suppl. 1), S410-S411. https://doi.org/10.1016/j.euroneuro.2018.11.624
  6. 2018
  7. Swen, J. J., Nijenhuis, M., van Rhenen, M., de Boer-Veger, N. J., Buunk, A-M., Houwink, E. J. F., ... Dutch Pharmacogenetics Working Group (DPWG) of the Royal Dutch Pharmacists Association (KNMP) (2018). Pharmacogenetic Information in Clinical Guidelines: The European Perspective. Clinical Pharmacology & Therapeutics, 103(5), 795-801. https://doi.org/10.1002/cpt.1049
  8. Toshchakova, V. A., Bakhtiari, Y., Kulikov, A. V., Gusev, S. I., Trofimova, M. V., Fedorenko, O. Y., ... Ivanova, S. A. (2018). Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders. Neuropsychobiology, 75(4), 200-210. https://doi.org/10.1159/000487484
  9. Ivanova, S. A., Alifirova, V. M., Pozhidaev, I. V., Freidin, M. B., Zhukova, I. A., Osmanova, D. Z., ... Loonen, A. J. M. (2018). Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia. Journal of pharmacy and pharmaceutical sciences, 21(1), 340-346. https://doi.org/10.18433/jpps29903
  10. 2017
  11. Osmanova, D., Boiko, A. S., Fedorenko, O. Y., Pozhidaev, I. V., Freidin, M. B., Kornetova, E. G., ... Loonen, A. J. M. (2017). Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophrenia. European Neuropsychopharmacology, 27(Suppl. 4), 923-924.
  12. Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Cohen, D., Boiko, A. S., ... Loonen, A. J. M. (2017). Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia. European Neuropsychopharmacology, 27(Supplement 4), S956. https://doi.org/10.1016/S0924-977X(17)31689-9
  13. Pozhidaev, I., Alifirova, V. M., Freidin, M. B., Zhukova, I. A., Fedorenko, O. Y., Osmanova, D. Z., ... Loonen, A. J. M. (2017). Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia. European Neuropsychopharmacology, 27(Supplement 4), S590. https://doi.org/10.1016/S0924-977X(17)31129-X
  14. Ivanova, S. A., Alifirova, V. M., Freidin, M. B., Pozhidaev, I. V., Fedorenko, O. Y., Bokhan, N. A., ... Loonen, A. J. M. (2017). Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease. European Neuropsychopharmacology, 27(Supplement 4), S1039-S1040. https://doi.org/10.1016/S0924-977X(17)31817-5
  15. Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Cohen, D., Boiko, A. S., ... Loonen, A. J. M. (2017). Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia. European Neuropsychopharmacology, 27, S956-S956.
  16. Pozhidaev, I., Alifirova, V. M., Freidin, M. B., Zhukova, I. A., Fedorenko, O. Y., Osmanova, D. Z., ... Loonen, A. J. M. (2017). Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia. European Neuropsychopharmacology, 27, S590-S590.
  17. Nuntamool, N., Ngamsamut, N., Vanwong, N., Puangpetch, A., Chamnanphon, M., Hongkaew, Y., ... Sukasem, C. (2017). Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents. Basic & clinical pharmacology & toxicology, 121(4), 316-324. https://doi.org/10.1111/bcpt.12803
  18. Ivanova, S. A., Alifirova, V. M., Freidin, M. B., Pozhidaev, I. V., Fedorenko, O. Y., Bokhan, N. A., ... Loonen, A. J. M. (2017). Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease. European Neuropsychopharmacology, 27, S1039-S1040.
  19. Ivanova (Svetlana A. Ivanova), S. A., Osmanova, D., Boiko, A., Pozhidaev, I., Fedorenko, O., Kornetova, E., ... Loonen, A. (2017). Association between prolactin gene polymorphism (-1149 G/T) and hyperprolactinemia in anti-psychotic treated patients with schizophrenia. European Psychiatry, 41, S267-S267. https://doi.org/10.1016/j.eurpsy.2017.02.087
  20. Boiko, A. S., Losenkov, I. S., Levchuk, L. A., Simutkin, G. G., Bokhan, N. A., Bosker, F. J., ... Ivanova (Svetlana Ivanova), S. A. (2017). Biomarkers of depressive disorders: A multiplex analysis of blood serum. European Psychiatry, 41, S524-S524. https://doi.org/10.1016/j.eurpsy.2017.01.699
Previous 1 2 3 4 5 6 7 Next

ID: 218810